Electroconvulsive therapy in the medically ill

Current Psychiatry Reports

Volumn 5, Issue 3, 2003, Pages 225-230

  Christopher, Eric J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRENOLOL; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; ESMOLOL; GLYCERYL TRINITRATE; GLYCOPYRRONIUM BROMIDE; INSULIN; IPRATROPIUM BROMIDE; LABETALOL; NICARDIPINE; THEOPHYLLINE;

ANTICHOLINERGIC EFFECT; ANTICOAGULANT THERAPY; ASYSTOLE; BLOOD DISEASE; BRAIN BLOOD FLOW; BRAIN DISEASE; BRONCHOSPASM; CARDIOVASCULAR DISEASE; COMORBIDITY; ELECTROCONVULSIVE THERAPY; EMBOLISM; EPILEPTIC STATE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; MAJOR DEPRESSION; MENTAL DISEASE; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYPHARMACY; RESPIRATORY TRACT DISEASE; REVIEW; RISK BENEFIT ANALYSIS; UNITED STATES;

EID: 3142681632     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-003-0047-8     Document Type: Review

References (57)

1. Accornero F: An eyewitness account of the discovery of electroshock. Convuls Ther 1988, 4:40-49.
2. Rosenbach ML, Hermann RC, Dorwart RA: Use of electroconvulsive therapy in the Medicare population between 1987 and 1992. Psychiatr Serv 1997, 49:1537-1542.
3. Kelly KG, Zisselman M: Update on electroconvulsive therapy in older adults. J Amer Geriatrics Soc 2000, 48:560-566.
4. A Task Force Report of the American Psychiatric Association: The Practice of Electroconvulsive Therapy Recommendations for Treatment, Training, and Privileging, edn 2. Washington, DC: American Psychiatric Association; 2001.
5. Lafferty JE, North CS, Spitznagel E, Isenberg K: Laboratory screening prior to ECT. J ECT 2001, 17:158-165.
6. Abramczuk JA, Rose NM: Pre-anesthetic assessment and the prevention of post-ECT morbidity. Br J Psychiatry 1979, 134:582-587.
7. Shiwach RS, Reid WH, Carmody TJ: An analysis of reported deaths following electroconvulsive therapy in Texas, 1993-1998. Psych Serv 2001, 52(8):1095-1097.
8. Scarano VR, Felthous AR, Early TS: The state of electroconvulsive therapy in Texas. Part I: reported data on 41,660 ECT treatments in 5971 patients. J Forensic Sci 2000, 45:1197-1202.
9. Eagle KA, Brundage BH, Chaitman BR, et al.: Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: report of the American College of Cardiology and American Heart Association Task Force on practice guidelines 1996. Circulation 1996, 93:1278.
10. Jiang W, Alexander J, Christopher E, et al.: Relationship of depression to increased risk of mortality and rehospitalization with congestive heart failure. Arch Intern Med 2001, 161:1849-1856.
11. Frasure-Smith N, Lesparance F, Talajic M: Depression following myocardial infarction: impact on 6-month survival. JAMA 1993, 270:1819-1825.
12. McCall WV: Asystole in electroconvulsive therapy: report of four cases. J Clin Psychiatry 1996, 57:199.
13. Burd J, Kettl P: Incidence of asystole in electroconvulsive therapy in elderly patients. Am J Geriatr Psychiatry 1998, 6:203.
14. Beyer JL, Weiner RD, Glenn MD: Electroconvulsive Therapy A Programmed Text, edn 2. Washington, DC: American Psychiatric Press; 1998.
15. O'Brien PD, Morgan DH: Bladder rupture during ECT. Convuls Ther 1991, 7:56-59.
16. Irving AD, Drayson AM: Bladder rupture during ECT. Br J Psychiatry 1984, 144:670.
17. Tess A, Smetana GW: Medical consultation for electroconvulsive therapy. UpToDate volume 10 number 2. http://www.uptodate.com/.
18. Stoudemire A: Cardiovascular complications of ECT [letter]. Am J Psychiatry 1994, 151:790.
19. Castelli I, Steiner LA, Kaufann MA, et al.: Comparative effects of esmolol and labetalol to attenuate hyperdynamic states after electroconvulsive therapy. Anesth Analg 1995, 80:557-561.
20. Fuenmayor AJ, El Fakih Y, Moreno J, Fuenmayor AM: Effects of electroconvulsive therapy on cardiac function in patients with out heart disease. Cardiology 1997, 88:254-257.
21. Kadoi Y, Saito S, Seki S, et al.: Electroconvulsive therapy impairs systolic performance of the left ventricle. Can J Anesth 2001, 48:405-408.
22. Lapid M, Rummans T, Hofmann V, et al.: ECT and automatic internal cardioverter-defibrillator. J ECT 2001, 17:146-148.
23. Ottaway A: Atrial fibrillation, failed cardioversion, and electroconvulsive therapy. Anaesth Intensive Care 2002, 30:215-218.
24. Gardner MW, Kellner CH, Hood DE, Hendrix GH: Safe administration of ECT in a patient with a cardiac aneurysm and multiple cardiac risk factors. Convuls Ther 1997, 13:200-203.
25. Rasmussen KG: Electroconvulsive therapy in patients with aortic stenosis. Convuls Ther 1997, 13:196-199.
26. Lee HB, Jayaram G, Teitelbaum ML: Electroconvulsive therapy for depression in a cardiac transplant patient. Psychosomatics 2001, 42:362-364.
27. Clary GL, Palmer SM, Doraiswamy PM: Mood disorders and chronic obstructive pulmonary disease: current research and future needs. Curr Psych Rep 2002, 4:213-221.
28. Rasmussen KG: Electroconvulsive therapy in patients taking theophylline. J Clin Psychiatry 1993, 54:427-431.
29. Viguera A, Welch C, Bigatello L, Drop LJ: Hemodynamic responses to electroconvulsive therapy in a hypertensive patient with end-stage pulmonary fibrosis. Anesth Analg 1998, 87:737-741.
30. Darnell JC, Jay SJ: Recurrent postictal pulmonary edema: a case report and review of the literature. Epilepsia 1982, 23:71-83.
31. Mulroy JJ, Mickell JJ, Tong TK, Pellock JM: Postictal pulmonary edema in children. Neurology 1985, 35:403-405.
32. Sinom RP: Physiologic consequences of status epilepticus. Epilepsia 1985, 26:S58-S66.
33. Terrence CF, Rao GR, Perper JA: Neurogenic pulmonary edema in unexpected, unexplained death of epileptic patients. Ann Neurol 1981, 9:458-464.
34. Buisseret P: Acute pulmonary edema following grand mal epilepsy and as a complication of electric shock therapy. Br J Dis Chest 1982, 76:194-198.
35. Wayne S, O'Donovan C, McCall W, et al.: Postictial neurogenic pulmonary edema: experience from an ECT model. Conv Therapy 1997, 13:181-184.
36. Chaturvedi S, Chadda RK, Rusia U, Jain N: Effect of electroconvulsive therapy on hematological parameters. Psychiatry Res 2001, 104:265-268.
37. Petrides G, Fink M: Atrial fibrillation, anticoagulation, and electroconvulsive therapy. Convuls Ther 1996, 12:91-98.
38. Kardener SH: EST in a patient with idiopathic thrombocytopenic purpura. Dis Nerv Syst 1968, 29:465-466.
39. Gonzalez-Arriaza HL, Mueller PS, Rummans TA: Successful electroconvulsive therapy in an elderly man with severe thrombocytopenia: case report and literature review. J ECT 2000, 17:198-200.
40. Sincoff RC, Giuffra LA, Blinder MA, Isenberg KE: Successful electroconvulsive therapy given to a patient with von Willebrand's disease. J ECT 2000, 16:68-70.
41. LaGrone D: ECT in secondary mania, pregnancy, and sickle cell anemia. Convuls Ther 1990, 6:176-180.
42. Nobler M, Sackeim H: Mechanisms of action of electroconvulsive therapy: functional brain imaging studies. Psychiatr Ann 1998, 28:23-29.
43. Patkar AA, Hill KP, Weinstein SP, Schwartz SL: ECT in the presence of brain tumor and increased intracranial pressure: evaluation and reduction of risk. J ECT 2000, 16:189-197.
44. Salaris S, Szuba MP, Traber K: ECT and intracranial vascular masses. J ECT 2000, 16:198-203.
45. Saad DA, Black JL, Krahn LE, Rummans TA: ECT post eye surgery: two cases and a review of literature. J ECT 2000, 16:409-414.
46. Madan S, Anderson K: ECT for a patient with a metallic skull plate. J ECT 2001, 17:289-291.
47. Kohler CG, Burock M: ECT for psychotic depression associated with a brain tumor [letter to the editor]. Am J Psychiatry 2001, 158:2089.
48. Moscarillo FM, Annunziata CM: ECT in a patient with a deep brain-stimulating electrode in place. J ECT 2000, 16:287-290
49. Saito S, Kadoi Y, Nara T, et al.: The comparative effects of propofol versus thiopental on middle cerebral artery blood flow velocity during electroconvulsive therapy. Anesth Analg 2000, 91:1531-1536.
50. Wajima Z, Yoshikawa T, Ogura A, et al.: Intravenous verapamil blunts hyperdynamic responses during electroconvulsive therapy without altering seizure activity. Anesth Analg 2002, 95:400-402.
51. Saito S, Kadoi Y, Iriuchijima N, et al.: Reduction of cerebral hyperemia with antihypertensive medication after electroconvulsive therapy. Can J Anesth 2000, 47:767-774.
52. Weiner RD, Coffey CE, Krystal AD: Electroconvulsive therapy in the medical and neurologic patient. In Psychiatric Care of the Medical Patient, edn 2. Edited by Stoudemire A, Fogel BS. New York: Oxford University Press; 2000:419-428.
53. Rasmussen KG, Rummans TA, Richardson JW: Electroconvulsive therapy in the medically ill. Psychiatr Clin North Am 2002, 25:177-193.
54. Normand PS, Jenike MA: Lowered insulin requirements after ECT. Psychosomatics 1984, 25:418-419.
55. Reddy S, Nobler MS: Dangerous hyperglycemia associated with electroconvulsive therapy. Convuls Ther 1996, 12:99-103.
56. Finestone DH, Weiner RD: Effects of ECT on diabetes mellitus: an attempt to account for conflicting data. Acta Psychiatr Scand 1984, 70:321-326.
57. Netzel PJ, Mueller PS, Rummans TA, et al.: Safety efficacy, and effects on glycemic control of electroconvulsive therapy in insulin-requiring type 2 diabetic patients. J ECT 2002, 18:16-21.